Retraction of: Scientific Reports https://doi.org/10.1038/s41598-025-86575-x, published online 04 February 2025
Authors have retracted this Article.
After publication of this Article, the Authors identified an error in Table 1 describing baseline characteristics of the patients. In that table, as a result of a clerical error during preparation of the manuscript, the clinical data of the TKI group was incorrectly labelled as the Rechallenge group, and vice versa. This error impacts Cox regression analyses the results of which are presented in Tables 2 and 3. The originally reported hazard ration and statistical significance in both univariate and multivariate models is incorrect. As such, the conclusion that chemotherapy challenge is an independent protective factor for OS and PFS no longer holds. This in turn invalidates the main conclusion of this study suggesting that rechallenge therapy is superior to the TKI in the matched cohort.
All Authors agree with the retraction and its wording.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Liu, C., Chen, J. & Liu, Y. Retraction Note: Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study. Sci Rep 15, 32520 (2025). https://doi.org/10.1038/s41598-025-14607-7
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-14607-7
